Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2025)
Historic Long-Term Investments for Zevra Therapeutics (ZVRA) over the last 5 years, with Q3 2025 value amounting to $30.9 million.
- Zevra Therapeutics' Long-Term Investments rose 40556.92% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year increase of 40556.92%. This contributed to the annual value of $6.0 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Zevra Therapeutics' Long-Term Investments stood at $30.9 million, which was up 40556.92% from $15.1 million recorded in Q2 2025.
- Over the past 5 years, Zevra Therapeutics' Long-Term Investments peaked at $33.5 million during Q2 2022, and registered a low of $6.0 million during Q4 2024.
- Its 4-year average for Long-Term Investments is $18.2 million, with a median of $16.3 million in 2022.
- Per our database at Business Quant, Zevra Therapeutics' Long-Term Investments skyrocketed by 3394.05% in 2022 and then skyrocketed by 40556.92% in 2025.
- Zevra Therapeutics' Long-Term Investments (Quarter) stood at $14.9 million in 2021, then skyrocketed by 33.94% to $20.0 million in 2022, then crashed by 69.95% to $6.0 million in 2024, then soared by 413.56% to $30.9 million in 2025.
- Its Long-Term Investments stands at $30.9 million for Q3 2025, versus $15.1 million for Q2 2025 and $6.1 million for Q1 2025.